European journal of pharmacologyDoxorubicinDrug SynergismHumansBreast NeoplasmsFemale
Synergistic anticancer effects of doxorubicin in combination with tilorone in breast cancer.
Abu Sufiyan Chhipa, Margherita Gallicchio, Valentina Boscaro, Snehal Patel
Published: 202510.1016/j.ejphar.2025.178249
Abstract
BACKGROUND: Tilorone is an orally active antiviral interferon inducer with anticancer effects. Doxorubicin has been previously reported to exhibit synergism with type 1 interferons. The present study investigated the anticancer effects of doxorubicin…
Preview only. Read the full abstract at the source